How to improve the cost effectiveness of oncology drug development A commentary on Tan et al. Anti-cancer drug resistance - Understanding the mechanisms through the use of integrative genomics and functional RNA interference

Christopher McCabe, John Smyth

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)2143-2144
Number of pages2
JournalEuropean Journal of Cancer
Issue number12
Publication statusPublished - Aug 2010

Cite this